Chilton Investment CO Inc. Adaptive Biotechnologies Corp Transaction History

Chilton Investment CO Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$30.02 - $39.87 $642,187 - $852,899	-21,392 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$32.22 - $44.59 $8.66 Million - $12 Million	-268,635 Reduced 92.62%	21,392 $874,000
Q1 2021 May 11, 2021	SELL	$37.26 - $67.74 $1.03 Million - $1.88 Million	-27,727 Reduced 8.73%	290,027 $11.7 Million
Q4 2020 Feb 11, 2021	BUY	$45.01 - $65.47 $5.81 Million - $8.44 Million	128,986 Added 68.33%	317,754 $18.8 Million
Q3 2020 Nov 09, 2020	BUY	$35.79 - $48.81 $5.2 Million - $7.1 Million	145,376 Added 335.03%	188,768 $9.18 Million
Q2 2020 Aug 05, 2020	BUY	$24.95 - $48.38 $1.08 Million - $2.1 Million	43,392 New	43,392 $2.1 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

Stay updated on Chilton Investment CO Inc. with notifications on news.